Registry Study of Traditional Morphology Grading Combined With Eeva in IVF Treatment
NCT ID: NCT01816802
Last Updated: 2015-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1200 participants
OBSERVATIONAL
2013-02-28
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlating Time-Lapse Parameters With aCGH Testing in IVF Treatment (aCGH Study)
NCT02141685
Eeva 12-well Dish Study
NCT01635036
Eeva System Imaging Study
NCT02301637
Eeva™ System Study: Noninvasive Recording and Visualization of Individual Embryos Cultured to Blastocyst Stage
NCT01369446
Correlating Time-Lapse Parameters Detected by the Eeva™ System With Comprehensive Chromosome Screening Results
NCT01635049
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
In-vitro fertilization using Eeva
Patients undergoing in-vitro fertilization treatment who provide informed consent and use Eeva in their treatment cycle.
In-vitro fertilization using Eeva
Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
In-vitro fertilization using Eeva
Eeva will image embryos through cleavage stage (Day 3). Embryologists will use Eeva results along with traditional morphological grading to assist in selecting embryo(s) for transfer or freezing.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* gestational carrier.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Progyny, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Shehua Shen, MD
Role: STUDY_DIRECTOR
Progyny, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
HRC Fertility
Encino, California, United States
Stanford Fertility and Reproductive Medicine Center
Palo Alto, California, United States
Reproductive Partners
Redondo Beach, California, United States
Pacific Fertility Center
San Francisco, California, United States
Center for Advanced Reproductive Services (UCHC)
Farmington, Connecticut, United States
Fertility Centers of Illinois - River North
Chicago, Illinois, United States
Northwestern Medical Faculty Foundation
Chicago, Illinois, United States
Fertility Centers of Illinois, Highland Park IVF Center
Highland Park, Illinois, United States
Long Island IVF
Melville, New York, United States
University Hospital Fertility Center
Beachwood, Ohio, United States
Institute for Reproductive Health
Cincinnati, Ohio, United States
Fertility Center of San Antonio
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Auxogyn, Inc. website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TST 2193-p
Identifier Type: OTHER
Identifier Source: secondary_id
2012-AUX-009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.